SCHEMBL7956165

SCHEMBL7956165

[CH2]CSC(c1cccc2ccccc12)c1cccc2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.48
CYP2C19 P33261 3/20 0.48
CYP1A2 P05177 2/20 0.48
ALDH1A1 P00352 2/20 0.48
SLC6A4 P31645 1/20 0.39
ACP3 P15309 2/20 0.38
AOC3 Q16853 1/20 0.38
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
CYP2A6 P11509 1/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11348133 0.77 ALDH1A1 (0.58) CYP2C9CYP2C19CYP1A2ALDH1A1SLC6A4
SCHEMBL3246866 0.74 ALDH1A1 (0.54) CYP2C9CYP2C19CYP1A2ALDH1A1SLC6A4
SCHEMBL28140563 0.72 CYP2C9 (0.52) CYP2C9CYP2C19CYP1A2ALDH1A1SLC6A4
SCHEMBL3255966 0.72 ALDH1A1 (0.62) CYP2C9CYP2C19CYP1A2ALDH1A1SLC6A4
SCHEMBL5011023 0.71 SLC6A4 (0.51) CYP2C9CYP2C19CYP1A2ALDH1A1SLC6A4
SCHEMBL8375779 0.71 CYP2C19 (0.50) CYP2C9CYP2C19CYP1A2ALDH1A1SLC6A4
SCHEMBL10734251 0.71 ALDH1A1 (0.50) CYP2C9CYP2C19CYP1A2ALDH1A1SLC6A4
SCHEMBL7453633 0.71 ALDH1A1 (0.50) CYP2C9CYP2C19CYP1A2ALDH1A1SLC6A4
SCHEMBL264495 0.71 ALDH1A1 (0.50) CYP2C9CYP2C19CYP1A2ALDH1A1SLC6A4
SCHEMBL2494544 0.69 ALDH1A1 (0.65) CYP2C9CYP2C19CYP1A2ALDH1A1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6323235-B1 CARDIOVASCULAR DISORDERS, ANTIISCHEMIC AGENTS AND ENZYME INHIBITORS OHTAKE ATSUSHI (JP) 2001-11-27 US disclosed
US-6043264-A A THROMBOXANE A2 RECEPTOR ANTAGONIST FOR TREATING HYPERTENSION, THROMBOSIS, ISCHEMIC HEART DISEASES, CIRCULATORY DISEASES, ARTERIOSCLEROSIS, PLATELET FUNCTION DISORDER, HYPERLIPIDEMIA, NEPHRITIS OR ASTHMA TORAY INDUSTRIES, INC. (JP) 2000-03-28 US disclosed
EP-0751126-A1 BENZENE-FUSED HETEROCYCLIC DERIVATIVE AND USE OF THE SAME TORAY INDUSTRIES, INC. (JP) 1997-01-02 EP disclosed